Cite
Novel benzenediamine derivative FC99 ameliorates zymosan-induced arthritis by inhibiting RORγt expression and Th17 cell differentiation.
MLA
Ji, Jianjian, et al. “Novel Benzenediamine Derivative FC99 Ameliorates Zymosan-Induced Arthritis by Inhibiting RORγt Expression and Th17 Cell Differentiation.” Acta Biochimica et Biophysica Sinica, vol. 46, no. 10, Oct. 2014, pp. 829–36. EBSCOhost, https://doi.org/10.1093/abbs/gmu074.
APA
Ji, J., Dou, H., Li, X., Song, Y., Li, X., Li, E., Tan, R., & Hou, Y. (2014). Novel benzenediamine derivative FC99 ameliorates zymosan-induced arthritis by inhibiting RORγt expression and Th17 cell differentiation. Acta Biochimica et Biophysica Sinica, 46(10), 829–836. https://doi.org/10.1093/abbs/gmu074
Chicago
Ji, Jianjian, Huan Dou, Xiaoqin Li, Yuxian Song, Xiaojing Li, Erguang Li, Renxiang Tan, and Yayi Hou. 2014. “Novel Benzenediamine Derivative FC99 Ameliorates Zymosan-Induced Arthritis by Inhibiting RORγt Expression and Th17 Cell Differentiation.” Acta Biochimica et Biophysica Sinica 46 (10): 829–36. doi:10.1093/abbs/gmu074.